Ebromin-P

How is the drug helping you?
advertisement

Ebromin-P uses

Ebromin-P consists of Ambroxol Hydrochloride, Clenbuterol Hydrochloride.

Clenbuterol Hydrochloride:



NADA 140-973, Approved by FDA

For oral use in horses only

Caution:

Federal law restricts this drug to use by or on the order of a licensed veterinarian.

Caution:

Federal law prohibits the extralabel use of this drug in food animals.

Each mL contains:

Ebromin-P (Clenbuterol Hydrochloride) HCl 72.5 mcg

Description:

Ebromin-P (Clenbuterol Hydrochloride) (4-amino-alpha-[(tert-butylamino) methyl]-3, 5-dichlorobenzyl alcohol hydrochloride) is a beta-2-adrenergic agonist which provides bronchodilating properties as well as other effects, with minimum effect on the cardiovascular system. It is provided as a colorless, palatable syrup. Ebromin-P (Clenbuterol Hydrochloride) Syrup (clenbuterol hydrochloride) is antagonized by beta-adrenergic blocking agents.

Indications:

Ebromin-P (Clenbuterol Hydrochloride) Syrup (clenbuterol hydrochloride) is indicated for the management of horses affected with airway obstruction, such as occurs in chronic obstructive pulmonary disease (COPD).

Contraindications:

Ebromin-P (Clenbuterol Hydrochloride) Syrup antagonizes the effects of prostaglandin F2 alpha and oxytocin. Ebromin-P (Clenbuterol Hydrochloride) Syrup should not be used in pregnant mares near term. Because tachycardia may occur, Ebromin-P (Clenbuterol Hydrochloride) Syrup should not be used in horses suspected of having cardiovascular impairment.

Warning:

The effect on reproduction in breeding stallions and brood mares has not been determined. Treatment starting with dosages higher than the initial dose is not recommended.

Human Warnings:

Not for human use. Do not use in horses intended for human consumption. Keep out of the reach of children. In case of accidental ingestion, contact a physician immediately. Ingestion of Ebromin-P (Clenbuterol Hydrochloride) Syrup may cause undesirable reactions. Ebromin-P (Clenbuterol Hydrochloride), like other beta adrenergic agonists, can produce significant cardiovascular effects in some people as evidenced by elevated pulse rate, blood pressure changes and/or ECG changes.

advertisement

Dosage and Administration:

Administer orally twice a day (b.i.d.). Initial dose is 0.5 mL/100 lbs body weight (0.8 mcg/kg) twice daily.

Dosage Schedule:

Initial

Dosage: administer 0.5 mL/100 lbs (0.8 mcg/kg) for 3 days (6 treatments);

If no improvement, administer 1.0 mL/100 lbs (1.6 mcg/kg) for 3 days (6 treatments);

If no improvement, administer 1.5 mL/100 lbs (2.4 mcg/kg) for 3 days (6 treatments);

If no improvement, administer 2.0 mL/100 lbs (3.2 mcg/kg) for 3 days (6 treatments);

If no improvement, horse is non-responsive to Ebromin-P (Clenbuterol Hydrochloride) and treatment should be discontinued.

Recommended duration of treatment at effective dose is 30 days. At the end of this 30-day treatment period, drug should be withdrawn to determine recurrence of signs. If signs return, the 30-day treatment regimen may be repeated. If repeating treatment, the step-wise dosage schedule should be repeated.

Directions for Administration:

Remove safety cap and seal; replace with enclosed plastic dispensing cap. Remove cover from dispensing tip and connect syringe (without needle). Draw out appropriate volume of Ebromin-P (Clenbuterol Hydrochloride) Syrup. Administer orally to the horse. Replace cover on dispensing tip to prevent leakage.

Dosage Calculation Chart


Lbs. Body

Weight


mL/treatment

at 0.5 mL/100#

(0.8 mcg/kg)


mL/treatment

at 1.0 mL/100#

(1.6 mcg/kg)


mL/treatment

at 1.5 mL/100#

(2.4 mcg/kg)


mL/treatment

at 2.0 mL/100#

(3.2 mcg/kg)


500

600

700

800

900

1000

1100

1200

1300

1400

1500

1600

1700

1800


2.5

3.0

3.5

4.0

4.5

5.0

5.5

6.0

6.5

7.0

7.5

8.0

8.5

9.0


5.0

6.0

7.0

8.0

9.0

10.0

11.0

12.0

13.0

14.0

15.0

16.0

17.0

18.0


7.5

9.0

10.5

12.0

13.5

15.0

16.5

18.0

19.5

21.0

22.5

24.0

25.5

27.0


10.0

12.0

14.0

16.0

18.0

20.0

22.0

24.0

26.0

28.0

30.0

32.0

34.0

36.0


Administer two treatments per day.

advertisement

Precaution:

The safety cap should be placed on the bottle when not in use.

Adverse Reactions:

Mild sweating, muscle tremor, restlessness, urticaria and tachycardia may be observed in some horses during the first few days of treatment. May cause elevated creatine kinase (CK) serum levels. Ataxia was observed in 3 out of 239 horses (1.3%) in clinical studies. To report suspected adverse reactions, to obtain a Material Safety Data Sheet (MSDS), or for technical assistance, call 1-866-638-2226.

How Supplied:

Ebromin-P (Clenbuterol Hydrochloride) Syrup is available in 100 mL, 330 mL and 460 mL plastic bottles containing 72.5 mcg Ebromin-P (Clenbuterol Hydrochloride) HCl per mL.

NDC 0010-3017-02 - 100 mL

NDC 0010-3017-03 - 330 mL

NDC 0010-3017-04 - 460 mL

Storage:

Store at or below 25°C (77°F). Avoid freezing.

Ebromin-P (Clenbuterol Hydrochloride) is a registered trademark of Boehringer Ingelheim Vetmedica GmbH.

Manufactured for:

Boehringer Ingelheim Vetmedica, Inc.

St. Joseph, MO 64506 U.S.A.

301704-04

090330771/1

330 mL Display Carton – Front, Top and Side Panel

Picture of 330 mL display carton front, top and side panel.

330 mL Display Carton – Back and Side Panel

Picture of 330 mL display carton - back and side panel.

advertisement

Ebromin-P pharmaceutical active ingredients containing related brand and generic drugs:

Active ingredient is the part of the drug or medicine which is biologically active. This portion of the drug is responsible for the main action of the drug which is intended to cure or reduce the symptom or disease. The other portions of the drug which are inactive are called excipients; there role is to act as vehicle or binder. In contrast to active ingredient, the inactive ingredient's role is not significant in the cure or treatment of the disease. There can be one or more active ingredients in a drug.


Ebromin-P available forms, composition, doses:

Form of the medicine is the form in which the medicine is marketed in the market, for example, a medicine X can be in the form of capsule or the form of chewable tablet or the form of tablet. Sometimes same medicine can be available as injection form. Each medicine cannot be in all forms but can be marketed in 1, 2, or 3 forms which the pharmaceutical company decided based on various background research results.
Composition is the list of ingredients which combinedly form a medicine. Both active ingredients and inactive ingredients form the composition. The active ingredient gives the desired therapeutic effect whereas the inactive ingredient helps in making the medicine stable.
Doses are various strengths of the medicine like 10mg, 20mg, 30mg and so on. Each medicine comes in various doses which is decided by the manufacturer, that is, pharmaceutical company. The dose is decided on the severity of the symptom or disease.


Ebromin-P destination | category:

Destination is defined as the organism to which the drug or medicine is targeted. For most of the drugs what we discuss, human is the drug destination.
Drug category can be defined as major classification of the drug. For example, an antihistaminic or an antipyretic or anti anginal or pain killer, anti-inflammatory or so.


Ebromin-P Anatomical Therapeutic Chemical codes:

A medicine is classified depending on the organ or system it acts [Anatomical], based on what result it gives on what disease, symptom [Therapeutical], based on chemical composition [Chemical]. It is called as ATC code. The code is based on Active ingredients of the medicine. A medicine can have different codes as sometimes it acts on different organs for different indications. Same way, different brands with same active ingredients and same indications can have same ATC code.


Ebromin-P pharmaceutical companies:

Pharmaceutical companies are drug manufacturing companies that help in complete development of the drug from the background research to formation, clinical trials, release of the drug into the market and marketing of the drug.
Researchers are the persons who are responsible for the scientific research and is responsible for all the background clinical trials that resulted in the development of the drug.


advertisement

References

  1. "clenbuterol". https://pubchem.ncbi.nlm.nih.gov/co... (accessed August 28, 2018).
  2. "ambroxol". https://pubchem.ncbi.nlm.nih.gov/co... (accessed August 28, 2018).
  3. "ambroxol". http://www.drugbank.ca/drugs/DB0674... (accessed August 28, 2018).

Frequently asked Questions

Can i drive or operate heavy machine after consuming Ebromin-P?

Depending on the reaction of the Ebromin-P after taken, if you are feeling dizziness, drowsiness or any weakness as a reaction on your body, Then consider Ebromin-P not safe to drive or operate heavy machine after consumption. Meaning that, do not drive or operate heavy duty machines after taking the capsule if the capsule has a strange reaction on your body like dizziness, drowsiness. As prescribed by a pharmacist, it is dangerous to take alcohol while taking medicines as it exposed patients to drowsiness and health risk. Please take note of such effect most especially when taking Primosa capsule. It's advisable to consult your doctor on time for a proper recommendation and medical consultations.

Is Ebromin-P addictive or habit forming?

Medicines are not designed with the mind of creating an addiction or abuse on the health of the users. Addictive Medicine is categorically called Controlled substances by the government. For instance, Schedule H or X in India and schedule II-V in the US are controlled substances.

Please consult the medicine instruction manual on how to use and ensure it is not a controlled substance.In conclusion, self medication is a killer to your health. Consult your doctor for a proper prescription, recommendation, and guidiance.

advertisement

Review

sdrugs.com conducted a study on Ebromin-P, and the result of the survey is set out below. It is noteworthy that the product of the survey is based on the perception and impressions of the visitors of the website as well as the views of Ebromin-P consumers. We, as a result of this, advice that you do not base your therapeutic or medical decisions on this result, but rather consult your certified medical experts for their recommendations.

Visitor reports

Visitor reported useful

No survey data has been collected yet

Visitor reported side effects

No survey data has been collected yet

Visitor reported price estimates

No survey data has been collected yet

Visitor reported frequency of use

No survey data has been collected yet

Elenen visitors reported doses

What is the dose of Ebromin-P drug you are taking?
According to the survey conducted among sdrugs.com website users, the maximum number of people are using the following dose 101-200mg. Few medications come in only one or two doses. Few are specific for adult dose and child dose. The dose of the medicine given to the patient depends on the severity of the symptom/disease. There can be dose adjustments made by the doctor, based on the progression of the disease. Follow-up is important.
Visitors%
101-200mg7
63.6%
51-100mg3
27.3%
6-10mg1
9.1%

Two visitors reported time for results

What is the time duration Ebromin-P drug must be taken for it to be effective or for it to reduce the symptoms?
Most chronic conditions need at least some time so the dose and the drug action gets adjusted to the body to get the desired effect. The stastistics say sdrugs.com website users needed 2 weeks to notice the result from using Ebromin-P drug. The time needed to show improvement in health condition after using the medicine Ebromin-P need not be same for all the users. It varies based on other factors.
Visitors%
2 weeks1
50.0%
3 days1
50.0%

Two visitors reported administration

The drugs are administered in various routes, like oral or injection form. They are administered before food or after food. How are you taking Ebromin-P drug, before food or after food?
Click here to find out how other users of our website are taking it. For any doubts or queries on how and when the medicine is administered, contact your health care provider immediately.
Visitors%
With a meal2
100.0%

Fourteen visitors reported age

Visitors%
> 603
21.4%
1-53
21.4%
6-152
14.3%
46-602
14.3%
16-292
14.3%
< 11
7.1%
30-451
7.1%

Visitor reviews


There are no reviews yet. Be the first to write one!


Your name: 
Email: 
Spam protection:  < Type 29 here

The information was verified by Dr. Rachana Salvi, MD Pharmacology

© 2002 - 2024 "sdrugs.com". All Rights Reserved